https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation

Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation

NRX-100 receives FDA fast track designation, offering hope for treating suicidal ideation in depression and bipolar disorder, addressing a critical health crisis.

administrator

Related Articles